By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that it has established a subsidiary in New Delhi, India, to sell its products directly to the Indian market.

The firm had been using distributors for its products in the country, but it believes setting up the new subsidiary will further its growth in the emerging market.

Qiagen expects the New Delhi office will have more than 30 employees by the end of this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.